Clin2
NCT05562609Possibly a fitRecruiting

Tranexamic acid to reduce heavy bleeding after childbirth

Postpartum Hemorrhage

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
30,000 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are in the hospital to give birth (vaginally or by C-section).
  • You have at least one known risk factor for heavy postpartum bleeding.
  • There is no clear reason you must not take tranexamic acid.
  • There is no clear reason you must take tranexamic acid right away for another situation.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07278037Recruiting
Tranexamic Acid for Postpartum Hemorrhage Trends

This study looks at how tranexamic acid, a medicine to reduce bleeding, is given to people who have heavy bleeding after a cesarean delivery. It may help doctors improve treatment for this condition.

Bangkoknoi, Bangkok
NCT04304625Recruiting· Phase 3
Tranexamic acid to reduce blood loss after C-section

This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.

Bordeaux
NCT06754371Recruiting· Phase 4
Tranexamic acid to prevent heavy bleeding after C-section in autoimmune disease

This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.

Shanghai, Shanghai Municipality
NCT07002749Not yet recruiting· Phase 1
Tranexamic acid to prevent heavy bleeding after planned C-section

This trial tests whether giving a medicine called tranexamic acid before a planned C-section can help prevent dangerous heavy bleeding after birth. It is for pregnant women with low-risk pregnancies who are scheduled for a planned C-section.

Karachi, Sindh
NCT06025916Recruiting· Phase 4
Reducing postpartum bleeding with oral tranexamic acid

This trial tests whether taking an oral medication called tranexamic acid can reduce heavy bleeding after childbirth in women planning a vaginal delivery. It may help you have a safer birth with less blood loss.

Stockholm
NCT05370820Recruiting· Phase 2
Tranexamic acid to prevent heavy bleeding after C-section

This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.

Washington D.C., District of Columbia

Hear when a new Postpartum Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.